The quality of a country's disease surveillance system determines how much it knows about the health threats it faces and how quickly it can respond to them.
Why Surveillance Is Governance
Disease surveillance — the systematic collection, analysis, and reporting of health data to detect and respond to disease threats — is a governance function as much as a technical one. The quality of the surveillance system determines what the health system knows about disease burden, outbreak development, and population health trends. That knowledge is the foundation of every subsequent governance decision about how to allocate health resources, where to target interventions, and when to escalate the response to an emerging threat. A health governance system operating without adequate surveillance is governing without the information that governance requires.
Surveillance as Early Warning
The most consequential function of disease surveillance is early warning — the identification of emerging threats before they have reached the scale that makes response much more difficult and expensive. The COVID-19 pandemic demonstrated both the value of early warning — countries that identified the outbreak early and responded quickly reduced their case counts by orders of magnitude relative to late responders — and the fragility of the surveillance systems that provide it. Many surveillance systems that appeared adequate in normal conditions were revealed as inadequate to the specific demands of pandemic surveillance.
Disease surveillance is the health system's most consequential investment relative to its cost — because the early warning it provides determines whether a responding institution is ahead of or behind the threat it is managing. Being ahead is exponentially cheaper than being behind.
Discussion